Apimeds Pharmaceuticals US Inc (APUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||
| Net Income | -6,001 | -1,390 | -778 |
| Depreciation Amortization | 6 | N/A | N/A |
| Other Working Capital | -2,821 | 539 | 42 |
| Other Operating Activity | -109 | 118 | 108 |
| Operating Cash Flow | $-8,926 | $-734 | $-628 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -2,000 | N/A | N/A |
| PPE Investments | -57 | N/A | N/A |
| Other Investing Activity | -8,003 | 0 | 0 |
| Investing Cash Flow | $-10,060 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 10,250 | 250 | N/A |
| Common Stock Issued | 11,630 | N/A | N/A |
| Other Financing Activity | -1,261 | 77 | 1,032 |
| Financing Cash Flow | $20,619 | $327 | $1,032 |
| Beginning Cash Position | 8,004 | 411 | 6 |
| End Cash Position | 9,637 | 4 | 411 |
| Net Cash Flow | $1,633 | $-407 | $404 |
| Free Cash Flow | |||
| Operating Cash Flow | -8,926 | -734 | -628 |
| Capital Expenditure | -57 | N/A | N/A |
| Free Cash Flow | -8,983 | -734 | -628 |